Browsing by Subject "Swenson College of Science & Engineering"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Effect of the Cooling Coefficient on Efficiency Loss in SFC(2012-04-18) Lusk, RyanSupercritical fluid chromatography (SFC) is becoming a rapid alternative to high performance liquid chromatography (HPLC) because the lower viscosity and higher diffusivity of the mobile phase due to critical conditions enables faster separations and the ability to use smaller stationary phase particle sizes. However, radial temperature gradients that form from expansion of the mobile phase across the column reduce its efficiency. The net cooling coefficient of the mobile phase at the column outlet is a major factor controlling that temperature drop. The experimental correlation between the net cooling coefficient and efficiency loss was examined by performing two series of experiments: one where the oven temperature was held constant at 50.0 °C and the column outlet pressure was varied to yield nominal net cooling coefficients ranging from 0.10 to 0.25 K/bar and another where the column outlet pressure was held constant at 148 bar and the oven temperature was varied to yield the same range of nominal net cooling coefficients. Plate height curves of both sets of experiments were produced to examine column efficiency. It was found that the elution profiles that shared the same net cooling coefficient but had different experimental conditions had nearly identical column efficiencies, indicating that the net cooling coefficient strongly predicts column efficiency.Item Mitochondrial capacity of chemotherapy resistant and sensitive lung cancer cells(2012-04-18) Zehowski, CherylLung cancer is a significant cause of mortality in the U.S., the leading among cancer deaths, and more research is needed to improve the clinical picture for patients. Drug resistance remains a barrier to successful treatment of cancer even with the ongoing development of new molecularly targeted therapies. In the diagnosis of cancer, the treatment is determined based on the parameters of the tumor. Non-invasive cancers are often cured by surgery alone, while cancers that have progressed past the lymph node stage are commonly treated with chemotherapy. Chemotherapy drugs are administered systemically and used to kill cancer cells and prevent cancerous cells from producing. There is not a definitive way to distinguish between a chemotherapy resistant or sensitive cancer tumor at the time of diagnosis which is wasting precious time for the patient if the treatment does not work. The main goal of the Skildum lab is to identify biomarkers specific for drug resistant cancer that will allow for earlier and more effective treatment decisions. We have established a model of cancer resistance, using MCF-7 (sensitive to chemotherapy) and LCC9 (less sensitive to chemotherapy treatment) breast cancer cells. We have shown that LCC9 cells have increased mitochondrial capacity and increased expression of the Tfam gene in comparison to the MCF-7 counterpart. Tfam is a major regulator of mitochondrial DNA replication and transcription. From here curiosity struck to discover if other forms of cancer have increased expression of the Tfam gene in the resistant form of cancer. If we are able to discover a gene that is uniquely expressed in a number of cancers, we may be able to target that gene as a biomarker in the diagnosis of cancer patients. The goal of the current work was to test whether mitochondrial capacity was elevated in a model of doxorubicin resistant human lung cancer. The techniques used were cell culture, sulforhodamine B assay and hemocytometer to verify doxorubicin treatment in the cells, DNA isolation for mtDNA expression and RNA isolation to express Tfam through qPCR. Preliminary results show that chemotherapy resistant lung cancer cells have increased mitochondrial DNA and Tfam expression in comparison with their sensitive lung cancer counterpart.